F
Franco Borzio
Researcher at University of Milan
Publications - 68
Citations - 4744
Franco Borzio is an academic researcher from University of Milan. The author has contributed to research in topics: Hepatocellular carcinoma & Liver cancer. The author has an hindex of 36, co-authored 68 publications receiving 4084 citations.
Papers
More filters
Journal ArticleDOI
Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.
TL;DR: In this paper, the thyroid function in patients with chronic hepatitis and chronic hepatitis was evaluated, showing that thyroid function was almost always maintained, probably as a result of low normal FT3 and high-normal FT4.
Journal ArticleDOI
The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis
Mauro Borzio,Franco Borzio,Roberto Maria Macchi,Anna Maria Croce,Savino Bruno,Angelo Ferrari,Ernesto Servida +6 more
TL;DR: Results indicate that, in patients with cirrhosis with nodular lesions < 30 mm, fine needle biopsy is superior to fine needle aspiration and that the combined evaluation of fine-needle aspiration plus intranodular and extranodULAR fine needleBiopsy is the most accurate approach.
Journal ArticleDOI
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use
Edoardo G. Giannini,Giorgio Sammito,Fabio Farinati,Francesca Ciccarese,A. Pecorelli,Gian Lodovico Rapaccini,Mariella Di Marco,Eugenio Caturelli,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Antonio Gasbarrini,Rodolfo Sacco,Francesco Giuseppe Foschi,Gabriele Missale,Filomena Morisco,Gianluca Svegliati Baroni,Roberto Virdone,Franco Trevisani +19 more
TL;DR: The authors evaluated the relevance of demographic, clinical, and oncologic factors to the presence of elevated AFP levels in large cohort of patients with HCC.
Journal ArticleDOI
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
Edoardo G. Giannini,Alessandro Moscatelli,Gaia Pellegatta,Alessandro Vitale,Fabio Farinati,Francesca Ciccarese,Fabio Piscaglia,Gian Lodovico Rapaccini,Maria Di Marco,Eugenio Caturelli,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Rodolfo Sacco,Filomena Morisco,Gabriele Missale,Francesco Giuseppe Foschi,Antonio Gasbarrini,Gianluca Svegliati Baroni,Roberto Virdone,Alberto Masotto,Franco Trevisani +22 more
TL;DR: The subclassification of the intermediate-stage HCC predicts the prognosis of patients with untreated HCC and the prognostic figures identified in this study may be used as a benchmark to assess the efficacy of therapeutic intervention in the various BCLC B substages.
Journal ArticleDOI
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population
Alessandro Cucchetti,Franco Trevisani,Matteo Cescon,Giorgio Ercolani,Fabio Farinati,Paolo Poggio,Gianludovico Rapaccini,Maria Anna Di Nolfo,Luisa Benvegnù,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Maria Chiaramonte,Antonio Daniele Pinna +14 more
TL;DR: Both surveillance strategies for HCC in cirrhotic patients can be recommended, according to the individual risk profile for H CC occurrence and the expected survival gain obtainable after tumor diagnosis and therapy.